Study finds nitric oxide does not help sickle cell pain crisis

Mar 01, 2011

Inhaling nitric oxide gas does not reduce pain crises or shorten hospital stays in people living with sickle cell disease, according to the results of a new study sponsored by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.

" for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis," will be published in the March 2 issue of the .

is an inherited disorder affecting between 70,000 and 100,000 Americans. The disease causes , which are normally disc-shaped and pliable, to become misshapen, stiff and sticky. Severe pain crises occur periodically in people living with sickle cell disease when these sickled red blood cells hinder proper blood flow.

Nitric oxide dilates and expands and enhances blood flow. Levels are lower in persons with sickle cell disease than in those without the disease. Previous trials with smaller numbers of patients had suggested that administration of nitric oxide might shorten sickle cell pain crises.

This study involved 150 sickle cell disease patients who were hospitalized for severe pain crises. Each participant was given nitric oxide gas or a placebo gas during treatment. Though the nitric oxide was well-tolerated, it failed to improve outcomes. The average length of pain crises among trial participants was 73 hours in the nitric oxide group compared with 65.5 hours in the placebo group, which was not statistically different. There was also no statistical difference between the two groups in average length of hospital stay or average painkiller usage.

Explore further: Gene mutation discovered in blood disorder

More information: Learn more about this trial at: clinicaltrials.gov/ct2/show/NCT00094887

JAMA. 2011;305[9]893-902.

Provided by National Institutes of Health

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Compound may prevent sickle cell pain crises

Feb 01, 2011

A new compound appears to prevent the traffic jam of cells that causes debilitating pain crises and associated mortality in sickle cell disease, Georgia Health Sciences University (formerly Medical College ...

Reducing side-effects of painkillers

Sep 12, 2006

Cardiff University researchers have increased the understanding of why some painkillers increase the risk of heart attack and stroke.

Sickle cell treatment enters Phase 3 clinical trial

Jul 23, 2010

An experimental treatment for sickle cell disease developed at the Los Angeles Biomedical Research Institute (LA BioMed) has entered Phase 3 clinical trials, David I. Meyer, PhD, LA BioMed president and CEO ...

Recommended for you

Developing 'tissue chip' to screen neurological toxins

6 minutes ago

A multidisciplinary team at the University of Wisconsin-Madison and the Morgridge Institute for Research is creating a faster, more affordable way to screen for neural toxins, helping flag chemicals that ...

Gene mutation discovered in blood disorder

4 hours ago

An international team of scientists has identified a gene mutation that causes aplastic anemia, a serious blood disorder in which the bone marrow fails to produce normal amounts of blood cells. Studying a family in which ...

Airway muscle-on-a-chip mimics asthma

6 hours ago

The majority of drugs used to treat asthma today are the same ones that were used 50 years ago. New drugs are urgently needed to treat this chronic respiratory disease, which causes nearly 25 million people ...

Lost protein could prevent hardening of the arteries

10 hours ago

(Medical Xpress)—Researchers have found that when the protein matrix metalloproteinase-14 (MMP-14) is reduced or lost, white blood cells, known as macrophages, become good and could prevent hardening of ...

User comments : 0